Contact
searchSearch
HMP Global

Volume 19 - Issue 5 - May, 2007

Case Report
Spontaneous Closure of an Iatrogenic Circumflex Coronary Artery-to-Coronary Vein Fistula
08/01/2008
Islam Bolad, MD; Lawrence P. O'Meallie, MD
Coronary artery fistulae are extremely rare1 and can either be congenital or acquired secondary to cardiac intervention or surgery. They have also been reported following acute myocardial infarction.2 The majority of these fistulae arise from...
Coronary artery fistulae are extremely rare1 and can either be congenital or acquired secondary to cardiac intervention or surgery. They have also been reported following acute myocardial infarction.2 The majority of these fistulae arise from...
Coronary artery fistulae are...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
9th Biennial International Andreas Gruentzig Society: New Developments in Gene
Therapy and Stem Cells for Angiogenesis in the
08/01/2008
Jorge A. Belardi, MD, PhD; Joseph D. Babb, MD; Sigrid Nikol, MD; William W. O'Neill, MD; Robert Simari, MD; Timothy D. Henry, MD
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
9th Biennial IAGS Meeting: From Gene Transfer to Cell Therapy
08/01/2008
Robert Simari, MD
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate...
08/01/2008
Journal of Invasive Cardiology
Case Report
A Case of Congenitally Corrected Transposition of the Great Arteries with Rare but Life-Threatening Ventricular Tachycardia and
08/01/2008
Surender Malhotra, MBBS; Rakesh N. Patel, MBBS, MD; Mahendra Mandawat, MBBS, MD
Congenitally corrected transposition of the great vessels (CCTGA) is a rare congenital heart defect (CHD) and constitutes less than 1% of all congenital heart disease. The two fundamental anatomic abnormalities in CCTGA consist of...
Congenitally corrected transposition of the great vessels (CCTGA) is a rare congenital heart defect (CHD) and constitutes less than 1% of all congenital heart disease. The two fundamental anatomic abnormalities in CCTGA consist of...
Congenitally corrected...
08/01/2008
Journal of Invasive Cardiology
Case Report
Ethanol Septal Ablation for Refractory Ventricular Tachycardia
08/01/2008
Ferdinand Leya, MD; Ravi K. Ramana, DO; David J. Wilber, MD
Case Study. A 56-year-old male with severe nonischemic cardiomyopathy and recurrent ventricular tachycardia (VT) presented to our cardiology clinic with complaints of intermittent palpitations and several implantable cardioverter...
Case Study. A 56-year-old male with severe nonischemic cardiomyopathy and recurrent ventricular tachycardia (VT) presented to our cardiology clinic with complaints of intermittent palpitations and several implantable cardioverter...
Case Study. A 56-year-old male...
08/01/2008
Journal of Invasive Cardiology
Case Report
Kugel’s Artery Arising from an Anomalous Left Circumflex Coronary Artery
08/01/2008
Kevin P. Theleman, MD; Charles M. Gottlich, MD; Jeffrey M. Schussler, MD
Case Report. A 65-year-old male with no known history of coronary disease presented with dyspnea on exertion and electrocardiographic (ECG) changes suggesting an old inferior infarct. Stress testing suggested ischemia based on ECG criteria....
Case Report. A 65-year-old male with no known history of coronary disease presented with dyspnea on exertion and electrocardiographic (ECG) changes suggesting an old inferior infarct. Stress testing suggested ischemia based on ECG criteria....
Case Report. A 65-year-old male...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
May
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers,The May 2007 issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a review article, clinical images, online case reports, and a continuation of discussions from the Biennial Andreas...
Dear Readers,The May 2007 issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a review article, clinical images, online case reports, and a continuation of discussions from the Biennial Andreas...
Dear Readers,The May 2007 issue...
08/01/2008
Journal of Invasive Cardiology
Case Report
Intracardiac Echocardiography Guidance for Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
08/01/2008
Felipe Fernandez-Vazquez, MD, PhD; Fernando Alfonso, MD, PhD, FESC; Diego Martín, MD
Treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) and refractory symptoms remains a challenge.1 Surgical septal myectomy remains the classical approach for these patients.2 This therapy is associated with good initial...
Treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) and refractory symptoms remains a challenge.1 Surgical septal myectomy remains the classical approach for these patients.2 This therapy is associated with good initial...
Treatment of patients with...
08/01/2008
Journal of Invasive Cardiology
Case Report
Aspergillus Prosthetic Valve Endocarditis Causing Functional Aortic Stenosis: Initial Case Report
08/01/2008
Kenneth G. Warner, MD; Carey D. Kimmelstiel, MD, FACC, FACP, MSCAI; Brian C. Downey, MD
Despite extensive advances in cardiology over the past 50 years, the definitive treatment for aortic stenosis remains unchanged. Aortic valve replacement, while employing enhanced prostheses, continues as an imperfect therapy with inherent...
Despite extensive advances in cardiology over the past 50 years, the definitive treatment for aortic stenosis remains unchanged. Aortic valve replacement, while employing enhanced prostheses, continues as an imperfect therapy with inherent...
Despite extensive advances in...
08/01/2008
Journal of Invasive Cardiology
Case Report
Acute Neuroform Stenting of a Symptomatic Petrous Dissection
08/01/2008
Elad I. Levy, MD; L. Nelson Hopkins, MD; Robert D. Ecker, MD
Only two therapies for acute stroke intervention have been approved by the U.S. Food and Drug Administration: intravenous tissue plasminogen activator (tPA) and the Merci retriever (Concentric Medical, Mountainview, California). Many patients...
Only two therapies for acute stroke intervention have been approved by the U.S. Food and Drug Administration: intravenous tissue plasminogen activator (tPA) and the Merci retriever (Concentric Medical, Mountainview, California). Many patients...
Only two therapies for acute...
08/01/2008
Journal of Invasive Cardiology
Case Report
Transcatheter Closure of Coronary Artery Fistula Complicated by Myocardial Infarction
08/01/2008
Qi-Ling Cao, MD; Ziyad M. Hijazi, MD, MPH; Rami Kharouf, MD
Coronary artery fistula (CAF) is a rare congenital cardiac anomaly in which a communication is present between a coronary artery and either a cardiac chamber or another vascular structure. It accounts for 0.2–0.45% of all congenital cardiac...
Coronary artery fistula (CAF) is a rare congenital cardiac anomaly in which a communication is present between a coronary artery and either a cardiac chamber or another vascular structure. It accounts for 0.2–0.45% of all congenital cardiac...
Coronary artery fistula (CAF) is...
08/01/2008
Journal of Invasive Cardiology
Case Report
Coronary Venous Angioplasty and Stenting for Biventricular Pacemaker Left Ventricular Lead Implantation
08/01/2008
Amgad N. Makaryus, MD; Loukas S. Boutis, MD, FACC, FSCAI; Bruce Goldner, MD; Chong H. Park, MD
Biventricular pacing (BVP) for the treatment of congestive heart failure is now one of the forefront therapies for heart failure patients who continue to have symptoms despite maximal medical therapy. Recent advances in lead technology and...
Biventricular pacing (BVP) for the treatment of congestive heart failure is now one of the forefront therapies for heart failure patients who continue to have symptoms despite maximal medical therapy. Recent advances in lead technology and...
Biventricular pacing (BVP) for...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Myocardial Ischemia Due to Kinking of Left Internal Mammary Artery Graft with the Expiratory Phase of Respiration
08/01/2008
Ravi K. Sureddi, MD; Rajesh Sachdeva, MD; Kunal Sarkar, MD
Case Presentation. A 58-year-old male presented with substernal chest pain that started while mowing his lawn. The chest pain radiated to the left shoulder and was not relieved with sublingual nitroglycerin. He had controlled hypertension and...
Case Presentation. A 58-year-old male presented with substernal chest pain that started while mowing his lawn. The chest pain radiated to the left shoulder and was not relieved with sublingual nitroglycerin. He had controlled hypertension and...
Case Presentation. A 58-year-old...
08/01/2008
Journal of Invasive Cardiology
Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery in the Emergent/Urgent Setting
08/01/2008
Edo Kaluski, MD; Alberto Hendler, MD; Izhak Zyssman, MD; Yosef Gurevich, MD; Alex Blatt, MD; Zvi Vered, MD; Ricardo Krakover, MD; Vladimir Danicek, MD
Significant left main coronary stenosis occurs in 5–7% of patients undergoing coronary angiography.1,2 Patients with “unprotected” left main coronary artery (ULMCA) disease treated medically have an estimated 3-year mortality rate of ...
Significant left main coronary stenosis occurs in 5–7% of patients undergoing coronary angiography.1,2 Patients with “unprotected” left main coronary artery (ULMCA) disease treated medically have an estimated 3-year mortality rate of ...
Significant left main coronary...
08/01/2008
Journal of Invasive Cardiology
An Evaluation of Fluoroscopy Time and Correlation with Outcomes after Percutaneous Coronary Intervention
08/01/2008
Stephen Balter, PhD; Tereza Pucelikova, MD; Gregg W. Stone, MD, FACC, FSCAI; Liz Kaufman, PhD; Martin B. Leon, MD; Martin Fahy, MSc; Alexandra J. Lansky, MD; George D. Dangas, MD, PhD; Roxana Mehran, MD; Jeffrey W. Moses, MD; Eugenia Nikolsky, MD, PhD
Advances in interventional cardiology are reflected in the increased complexity of percutaneous coronary interventions (PCI). This leads to an increasing use of fluoroscopic guidance in these procedures with a concomitant increase in concern...
Advances in interventional cardiology are reflected in the increased complexity of percutaneous coronary interventions (PCI). This leads to an increasing use of fluoroscopic guidance in these procedures with a concomitant increase in concern...
Advances in interventional...
08/01/2008
Journal of Invasive Cardiology
COMMENTARY: Fluoroscopy Times and Adverse Events: A Potentially Deadly Combination
08/01/2008
Lawrence A. Garcia, MD, FACC, FAHA; Troy A. Bunting, MD
Endovascular treatment has become the predominant method of revascularization for arterial obstructive disease for both coronary and peripheral vascular disease. As such, radiation exposure and fluoroscopy times during percutaneous coronary...
Endovascular treatment has become the predominant method of revascularization for arterial obstructive disease for both coronary and peripheral vascular disease. As such, radiation exposure and fluoroscopy times during percutaneous coronary...
Endovascular treatment has...
08/01/2008
Journal of Invasive Cardiology
Should Patients in Cardiogenic Shock Undergo Rescue Angioplasty after Failed Fibrinolysis? Comparison of Primary versus Rescue A
08/01/2008
Mark A. de Belder, MA, MD, FRCP; Babu Kunadian, MBBS, MRCP; Andrew R. Thornley, MB, MRCP; Kunadian Vijayalakshmi, MBBS, MRCP; Joel Dunning, MRCS, PhD; Douglas F. Muir, MB, MRCP; Robert A. Wright, MD, FRCP; James A. Hall, MA, MD, FRCP; Andrew G.C. Sutton, MA, MD, MRCP
Cardiogenic shock is the leading cause of death in patients with acute myocardial infarction (AMI) who reach the hospital alive.1,2 The reported incidence of cardiogenic shock in patients with AMI is 7–10%.1,3 The mortality rate in these...
Cardiogenic shock is the leading cause of death in patients with acute myocardial infarction (AMI) who reach the hospital alive.1,2 The reported incidence of cardiogenic shock in patients with AMI is 7–10%.1,3 The mortality rate in these...
Cardiogenic shock is the leading...
08/01/2008
Journal of Invasive Cardiology
COMMENTARY: Cardiogenic Shock — The Role of Revascularization after Failed Thrombolysis
08/01/2008
Robert S. Dieter, MD, RVT; Pranab Das, MD; Aravinda Nanjundappa, MD, RVT, MBA
Technological advancements have revolutionized the field of interventional cardiology by introducing newer devices and better pharmacological agents. The incidence of cardiogenic shock (CS) complicating acute myocardial infarction (AMI)...
Technological advancements have revolutionized the field of interventional cardiology by introducing newer devices and better pharmacological agents. The incidence of cardiogenic shock (CS) complicating acute myocardial infarction (AMI)...
Technological advancements have...
08/01/2008
Journal of Invasive Cardiology
The Safety of a Bivalirudin-Based Approach in Patients undergoing Rotational Atherectomy
08/01/2008
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI; Hitinder S. Gurm, MBBS, MD, FSCAI; Vivek Rajagopal, MD; Stephen G. Ellis, MD; Michael Lincoff, MD
While contemporary percutaneous coronary intervention (PCI) is predominantly a stent-based strategy, other modalities are occasionally used in lieu of or in addition to stents. Rotational atherectomy uses a high-speed rotating bit to...
While contemporary percutaneous coronary intervention (PCI) is predominantly a stent-based strategy, other modalities are occasionally used in lieu of or in addition to stents. Rotational atherectomy uses a high-speed rotating bit to...
While contemporary percutaneous...
08/01/2008
Journal of Invasive Cardiology
Validation of a Predictive Risk Score for Radiocontrast-Induced Nephropathy following Percutaneous Coronary Intervention
08/01/2008
William W. O'Neill, MD; Charanjit S. Rihal, MD, MBA, FSCAI; Kimberly A. Skelding, MD, FACC, FAHA, FSCAI; Patricia J.M. Best, MD; Beth A. Bartholomew, MD; Ryan J. Lennon, MS
Percutaneous diagnostic and therapeutic cardiovascular procedures rely on intravascular use of iodinated radiocontrast agents for visualization in the cardiac catheterization laboratory. The use of radiocontrast agents has been associated...
Percutaneous diagnostic and therapeutic cardiovascular procedures rely on intravascular use of iodinated radiocontrast agents for visualization in the cardiac catheterization laboratory. The use of radiocontrast agents has been associated...
Percutaneous diagnostic and...
08/01/2008
Journal of Invasive Cardiology
Review
HIV Disease in Thrombocardiology
08/01/2008
William A. Van Decker, MD; Rasih Atilla Ener, MD; Brian O'Murchu, MD; Nelson M. Wolf, MD; James A. Burke, MD, PhD; Jason Palermo, MD
HIV Disease Human immunodeficiency virus (HIV) infection results from one of two similar retroviruses (HIV-1 and HIV-2) that destroy CD4+ lymphocytes and impair cell-mediated immunity, affecting multiple organ systems, increasing the risk of...
HIV Disease Human immunodeficiency virus (HIV) infection results from one of two similar retroviruses (HIV-1 and HIV-2) that destroy CD4+ lymphocytes and impair cell-mediated immunity, affecting multiple organ systems, increasing the risk of...
HIV Disease Human...
08/01/2008
Journal of Invasive Cardiology

News

thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

Bangalore top 10
Author Interview
Editor’s 2025 Top 10: Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease
02/02/2026
Sripal Bangalore, MD, MHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Editor's 2025 Top 10
Editor's Message
Editor’s 2025 Top 10
02/02/2026
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
Sovari Figure 1
Clinical Videos
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a...
01/28/2026
Journal of Invasive Cardiology
Bradt Figure
Clinical Videos
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal...
01/28/2026
Journal of Invasive Cardiology
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Heart Failure Devices
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
01/27/2026
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected...
01/27/2026
Cath Lab Digest
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a...
01/27/2026
Cath Lab Digest

May 2007 Volume 19 Issue 5

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use